Medaxes is the Belgian association of pharmaceutical companies that want to contribute to making healthcare accessible to all.
Medaxes focuses on generic and biosimilar medicines, as well as on other off-patent medicines and self-care products.
Off patent medicines account for 70% of those dispensed in Europe for the most prominent diseases such as cancer, diabetes, cardiovascular care, infectious diseases, and others. Between 70-90% of Intensive Care Unit (ICU), and emergency medicines are off patent. Our sector currently has over 400 manufacturing sites in Europe. Therefore, the off patent medicines industry sector must be included in the 'Important Project of Common European Interest' (IPCEI) on Health.
Please find here the press release of our European association, Medicines for Europe.
Scroll down or discover here the updated (October 2021) Facts & Figures Generic medicines in Belgium brochure.